v3.26.1
Consolidated Statement Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities [Abstract]    
Net loss $ (3,041,605) $ (3,719,621)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 137,220 150,269
Stock-based compensation 220,932 44,548
Issuance of advisory common stock shares 693,659  
Amortization of debt discounts 173,124 102,571
Reserve for expected credit losses 17,864 (44,413)
Impairment of intangible assets and goodwill 110,402  
Change in fair value of derivative liabilities 49,216  
Change in fair value of SAFE 10,426 0
Noncash amortization of debt financing costs 42,051 118,340
Inventory obsolescence (259,387) (6,615)
Loss on sale of securities at fair value   280,143
Changes in operating assets and liabilities    
Accounts receivable (807,911) 77,640
Inventory, net (807,742) 1,032,963
Prepaid expenses and other current assets (177,867) (121,239)
Accounts payable 1,331,352 (401,196)
Accrued expenses 576,356 (218,326)
Interest payable 16,348 1,986,281
Customer deposits (3,162)  
Contract liabilities (80,878) (2,122)
Net cash used in operating activities (1,799,602) (720,777)
Cash flows from investing activities    
Advances to related parties   (26,172)
Sale of investment   500,000
Proceeds from notes receivable   143,517
Proceeds from deposit on investment repurchase 300,000  
Purchase of SAFE (38,673) 0
Purchase of Investment   (43,118)
Net cash provided by investing activities 261,327 574,227
Cash flows from financing activities    
Proceeds from (repayments of) secured credit facility, net (348,873) (849,994)
Repayments of loans payable (97,854) (61,835)
Proceeds from issuance of promissory note   945,000
Proceeds from issuance of convertible notes payable 1,351,675  
Offering costs (37,315) (106,970)
Proceeds from exercise of stock options 1,260 375
Proceeds from exercise of warrants 836,226 51,408
Net cash provided by financing activities 1,705,119 (22,016)
Net change in cash and cash equivalents 166,844 (168,566)
Cash and cash equivalents, beginning of the period 824,962 693,946
Cash and cash equivalents, end of the period 991,806 525,380
Supplemental Disclosure of Cash Flow Information    
Cash paid for income taxes 15,739 26,408
Cash paid for interest 96,830 1,245,542
Noncash Investing and Financing Activities    
Conversion of promissory note to Preferred Stock   293,398
Warrant exercise for reduction of loans payable 150,000  
Repurchase of common stock through cancellation of balance due from related-party 1,393,713  
Discount from derivative liability $ 1,120,527  
Issuance of SAFE for reduction of promissory note principal   $ 500,000